2005
DOI: 10.1016/j.jtcvs.2004.07.038
|View full text |Cite
|
Sign up to set email alerts
|

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience

Abstract: Noguchi type A and B tumors may well be in situ carcinomas, and frozen-section examination was highly accurate. Neither local recurrence nor distant metastases have been found to date. Limited resection initial results appear promising.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
127
0
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 166 publications
(131 citation statements)
references
References 19 publications
3
127
0
1
Order By: Relevance
“…In the trial reported by YOSHIDA et al [61], this intra-operative assessment took ,1 h. There was agreement with the definitive post-operative pathological study in all specimens but one, which was changed from Noguchi's type B to C. However, other authors have reported difficulties in assessing the difference between BAC, atypical adenomatous hyperplasia, peripheral carcinoid tumours and other lesions [65]. If the intra-operative diagnosis of BAC is certain to the best of the pathologist's knowledge, then, according to the results of the series shown in table 2, a sublobar resection with no nodal dissection may be enough to ensure complete resection.…”
Section: Combined Therapiesmentioning
confidence: 97%
See 1 more Smart Citation
“…In the trial reported by YOSHIDA et al [61], this intra-operative assessment took ,1 h. There was agreement with the definitive post-operative pathological study in all specimens but one, which was changed from Noguchi's type B to C. However, other authors have reported difficulties in assessing the difference between BAC, atypical adenomatous hyperplasia, peripheral carcinoid tumours and other lesions [65]. If the intra-operative diagnosis of BAC is certain to the best of the pathologist's knowledge, then, according to the results of the series shown in table 2, a sublobar resection with no nodal dissection may be enough to ensure complete resection.…”
Section: Combined Therapiesmentioning
confidence: 97%
“…Table 2 summarises the data from nine Japanese reports focused on the surgical treatment of small BACs, currently f2 cm in diameter or less, although two series include larger tumours [13,[55][56][57][58][59][60][61][62]. In most reports, these small BACs represent ,2% of the lung cancer series, and were treated by either lobectomy or sublobar resection.…”
Section: Combined Therapiesmentioning
confidence: 99%
“…The authors stated that they had reviewed 11 thousand citations from which they selected 312 that 'met specified eligibility.' The citations supporting their notion, interestingly, have been presented as series of bronchioloalveolar carcinomas or small adenocarcinomas (o2 cm) [29][30][31][32][33][34][35][36][37][38][39][40][41] (Table 5). In some of these, the actual size of the tumor has been at best vague leaving the impression that some of these lesions may not even qualify as adenocarcinoma, but would rather have to be classified as atypical adenomatous hyperplasia (tumors with lepidic growth and size r0.5 cm).…”
Section: Discussionmentioning
confidence: 98%
“…The standard of care for early stage lung ADC is lobectomy, but segmentectomies and wedge resections are now more common alternatives, particularly for small (<2 cm) lesions (42). Radiologic evidence has shown the wedge/ segmentectomy may be appropriate for small tumors with a ground glass or predominantly ground glass appearance (43,44). These tumors for the most part correspond to AIS and MIA (38).…”
Section: Treatment Implications Of the New Classification Systemmentioning
confidence: 99%
“…These tumors for the most part correspond to AIS and MIA (38). While pure ground glass tumors have a 100% DFS survival after limited resection there are instances, albeit rare, where recurrences have occurred at the resection margin (44).…”
Section: Treatment Implications Of the New Classification Systemmentioning
confidence: 99%